C
Ultralife Corporation ULBI
$9.04 -$0.01-0.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 1/4/2024Upgraded
Ultralife Corporation (ULBI) was upgraded to C from D- on 1/4/2024 due to a significant increase in the efficiency index, valuation index and total return index. Total capital increased 2.23% from $146.48M to $149.75M.
D
Sell 7/21/2023Upgraded
Ultralife Corporation (ULBI) was upgraded to D- from E+ on 7/21/2023 due to an increase in the volatility index, total return index and growth index.
E
Sell 4/6/2023Downgrade
Ultralife Corporation (ULBI) was downgraded to E+ from D on 4/6/2023 due to a significant decline in the efficiency index, solvency index and volatility index. Total capital declined 0.12% from $140.08M to $139.92M.
D
Sell 3/15/2022Downgrade
Ultralife Corporation (ULBI) was downgraded to D from D+ on 3/15/2022 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 93.33% from -$585 to -$1.13M.
D
Sell 12/9/2021Downgrade
Ultralife Corporation (ULBI) was downgraded to D+ from C- on 12/9/2021 due to a decline in the total return index and volatility index.
C
Hold 11/3/2021Downgrade
Ultralife Corporation (ULBI) was downgraded to C- from C on 11/3/2021 due to a decline in the valuation index, volatility index and growth index. Earnings per share declined from $0.05 to -$0.04, EBIT declined 171.4% from $1.09M to -$779, and operating cash flow declined 50.62% from $3.05M to $1.51M.
C
Hold 7/29/2021Upgraded
Ultralife Corporation (ULBI) was upgraded to C from C- on 7/29/2021 due to an increase in the total return index and volatility index.
C
Hold 7/14/2021Downgrade
Ultralife Corporation (ULBI) was downgraded to C- from C on 7/14/2021 due to a decline in the total return index.
C
Hold 6/9/2021Upgraded
Ultralife Corporation (ULBI) was upgraded to C from C- on 6/9/2021 due to an increase in the total return index and volatility index.
C
Hold 5/3/2021Downgrade
Ultralife Corporation (ULBI) was downgraded to C- from C on 5/3/2021 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.1322 to $0.04, net income declined 68.17% from $2.11M to $671, and EBIT declined 21.65% from $1.22M to $952.
C
Hold 3/25/2021Upgraded
Ultralife Corporation (ULBI) was upgraded to C from C- on 3/25/2021 due to an increase in the total return index.
C
Hold 3/4/2021Downgrade
Ultralife Corporation (ULBI) was downgraded to C- from C on 3/4/2021 due to a decline in the volatility index and total return index.
C
Hold 2/17/2021Upgraded
Ultralife Corporation (ULBI) was upgraded to C from C- on 2/17/2021 due to an increase in the volatility index and total return index.
C
Hold 2/5/2021Upgraded
Ultralife Corporation (ULBI) was upgraded to C- from D+ on 2/5/2021 due to a major increase in the growth index, valuation index and total return index. Earnings per share increased from $0.0256 to $0.1322, EBIT increased 71.85% from $707 to $1.22M, and total revenue increased 18.94% from $24.36M to $28.98M.
D
Sell 10/30/2020Downgrade
Ultralife Corporation (ULBI) was downgraded to D+ from C- on 10/30/2020 due to a substantial decline in the growth index, volatility index and total return index. Earnings per share declined from $0.1 to $0.0256, EBIT declined 69.18% from $2.29M to $707, and total revenue declined 14.7% from $28.56M to $24.36M.
C
Hold 9/25/2020Downgrade
Ultralife Corporation (ULBI) was downgraded to C- from C on 9/25/2020 due to a decline in the total return index, valuation index and efficiency index. Total capital declined 3.21% from $128.78M to $124.65M.
C
Hold 4/17/2020Upgraded
Ultralife Corporation (ULBI) was upgraded to C from C- on 4/17/2020 due to an increase in the volatility index and total return index.
C
Hold 4/2/2020Downgrade
Ultralife Corporation (ULBI) was downgraded to C- from C on 4/2/2020 due to a substantial decline in the valuation index, total return index and efficiency index.
C
Hold 12/24/2019Downgrade
Ultralife Corporation (ULBI) was downgraded to C from C+ on 12/24/2019 due to a decline in the volatility index and total return index.
C
Hold 12/5/2019Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 12/5/2019 due to a substantial decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.14 to $0.0569, EBIT declined 57.07% from $3.04M to $1.31M, and debt to equity increased from 0.15 to 0.17.
B
Buy 10/23/2019Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 10/23/2019 due to an increase in the total return index, volatility index and valuation index.
C
Hold 8/26/2019Upgraded
Ultralife Corporation (ULBI) was upgraded to C+ from C on 8/26/2019 due to a large increase in the growth index, efficiency index and volatility index. EBIT increased 455.11% from $548 to $3.04M, net income increased 430.82% from $425 to $2.26M, and earnings per share increased from $0.027 to $0.14.
C
Hold 7/31/2019Downgrade
Ultralife Corporation (ULBI) was downgraded to C from C+ on 7/31/2019 due to a significant decline in the total return index.
C
Hold 5/7/2019Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 5/7/2019 due to a major decline in the growth index and valuation index. Operating cash flow declined 116.24% from $3.36M to -$545, earnings per share declined from $1.2129 to $0.027, and EBIT declined 48.64% from $1.07M to $548.
B
Buy 3/29/2019Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 3/29/2019 due to a significant increase in the total return index, valuation index and volatility index.
C
Hold 1/28/2019Upgraded
Ultralife Corporation (ULBI) was upgraded to C+ from C on 1/28/2019 due to an increase in the volatility index.
C
Hold 12/7/2018Downgrade
Ultralife Corporation (ULBI) was downgraded to C from C+ on 12/7/2018 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 3.29 to 3.2.
C
Hold 10/19/2018Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 10/19/2018 due to a significant decline in the total return index and volatility index.
B
Buy 6/15/2018Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 6/15/2018 due to an increase in the total return index and volatility index.
C
Hold 5/15/2018Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 5/15/2018 due to a decline in the valuation index and volatility index.
B
Buy 5/7/2018Downgrade
Ultralife Corporation (ULBI) was downgraded to B- from B on 5/7/2018 due to a significant decline in the growth index. Operating cash flow declined 125.49% from $3.61M to -$921, and earnings per share declined from $0.238 to $0.13.
B
Buy 3/21/2018Upgraded
Ultralife Corporation (ULBI) was upgraded to B from B- on 3/21/2018 due to a major increase in the total return index and volatility index.
B
Buy 2/12/2018Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 2/12/2018 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 1,073.85% from -$371 to $3.61M, net income increased 246.08% from $1.1M to $3.8M, and earnings per share increased from $0.07 to $0.238.
C
Hold 2/2/2018Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 2/2/2018 due to a decline in the volatility index, valuation index and total return index.
B
Buy 1/18/2018Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 1/18/2018 due to an increase in the volatility index and total return index.
C
Hold 1/3/2018Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 1/3/2018 due to a decline in the valuation index and volatility index.
B
Buy 11/28/2017Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 11/28/2017 due to an increase in the valuation index.
C
Hold 11/13/2017Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 11/13/2017 due to a significant decline in the total return index.
B
Buy 10/25/2017Downgrade
Ultralife Corporation (ULBI) was downgraded to B- from B on 10/25/2017 due to a decline in the total return index and valuation index.
B
Buy 9/26/2017Upgraded
Ultralife Corporation (ULBI) was upgraded to B from B- on 9/26/2017 due to a major increase in the total return index and volatility index.
B
Buy 9/18/2017Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 9/18/2017 due to an increase in the total return index and volatility index.
C
Hold 9/1/2017Downgrade
Ultralife Corporation (ULBI) was downgraded to C+ from B- on 9/1/2017 due to a decline in the total return index.
B
Buy 5/31/2017Upgraded
Ultralife Corporation (ULBI) was upgraded to B- from C+ on 5/31/2017 due to an increase in the total return index.
C
Hold 5/10/2017Upgraded
Ultralife Corporation (ULBI) was upgraded to C+ from C on 5/10/2017 due to a significant increase in the growth index, total return index and valuation index. EBIT increased 11.98% from $1.64M to $1.84M, and total revenue increased 1.9% from $21.63M to $22.04M.
C
Hold 7/29/2016Upgraded
Ultralife Corp. (ULBI) was upgraded to C from C- on 7/29/2016 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 172.1% from -$2.88M to $2.07M, earnings per share increased from $0.0195 to $0.0292, and net income increased 49.16% from $299 to $446.
C
Hold 3/14/2016Downgrade
Ultralife Corp. (ULBI) was downgraded to C- from C on 3/14/2016 due to a decline in the volatility index.
C
Hold 3/11/2016Downgrade
Ultralife Corp. (ULBI) was downgraded to C from B- on 3/11/2016 due to a significant decline in the volatility index and total return index.
B
Buy 3/9/2016Downgrade
Ultralife Corp. (ULBI) was downgraded to B- from B on 3/9/2016 due to a significant decline in the total return index, growth index and efficiency index. Operating cash flow declined 58.14% from $2.68M to $1.12M, earnings per share declined from $0.067 to $0.0305, and net income declined 52.05% from $1.05M to $502.
B
Buy 10/30/2015Upgraded
Ultralife Corp. (ULBI) was upgraded to B from B- on 10/30/2015 due to a significant increase in the total return index, growth index and efficiency index. Operating cash flow increased 69.27% from $1.59M to $2.68M, EBIT increased 43.57% from $817 to $1.17M, and earnings per share increased from $0.0476 to $0.067.
B
Buy 8/4/2015Upgraded
Ultralife Corp. (ULBI) was upgraded to B- from C- on 8/4/2015 due to a substantial increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.03 to $0.0476, and net income increased 47.84% from $533 to $788.
C
Hold 8/3/2015Upgraded
Ultralife Corp. (ULBI) was upgraded to C- from D+ on 8/3/2015 due to a significant increase in the volatility index, total return index and growth index. EBIT increased 47.58% from $557 to $822.
D
Sell 9/15/2014Upgraded
Ultralife Corp. (ULBI) was upgraded to D+ from D on 9/15/2014 due to an increase in the total return index, growth index and valuation index.
D
Sell 8/11/2014Downgrade
Ultralife Corp. (ULBI) was downgraded to D from D+ on 8/11/2014 due to a major decline in the growth index, volatility index and total return index. Operating cash flow declined 163.54% from $2.7M to -$1.72M, and total revenue declined 0.56% from $15.29M to $15.2M.
D
Sell 4/17/2014Downgrade
Ultralife Corp. (ULBI) was downgraded to D+ from C- on 4/17/2014 due to a decline in the total return index.
C
Hold 4/2/2014Upgraded
Ultralife Corp. (ULBI) was upgraded to C- from D+ on 4/2/2014 due to a noticeable increase in the growth index, volatility index and total return index.
D
Sell 3/18/2014Downgrade
Ultralife Corp. (ULBI) was downgraded to D+ from C- on 3/18/2014 due to a substantial decline in the valuation index, growth index and efficiency index. Operating cash flow declined 953.42% from -$644 to $5.5M, net income declined 89.29% from $644 to $69, and earnings per share declined from $0.036 to $0.0057.
Weiss Ratings